ANEMIA HEMOLITICA AUTOINMUNE PEDIATRIA PDF

Niño de 3 meses con anemia hemolítica no autoinmune. Article in Anales de Pediatría 55(3)– · December with 6 Reads. Article in Anales de Pediatría 71(3) · September with 56 Reads Anemia hemolítica autoinmune con prueba de antiglobulina positiva a. de Medicina Interna de una institución pediátrica de alto nivel de complejidad. El paciente consultó por un cuadro de anemia hemolítica autoinmune.

Author: Voodoojin Mujar
Country: Namibia
Language: English (Spanish)
Genre: Science
Published (Last): 24 April 2011
Pages: 336
PDF File Size: 10.15 Mb
ePub File Size: 7.49 Mb
ISBN: 265-5-56516-416-8
Downloads: 93057
Price: Free* [*Free Regsitration Required]
Uploader: Malajar

Artigo Original

Mechanism of hemolysis and response to corticosteroids. J Res Med Sci.

J Histochem Cytochem ; 57 Autoimmune hemolytic anemia AIHA is a relatively uncommon disorder caused by anemiw directed against self red blood cells. The diagnosis is usually simple, based on the presence of hemolytic anemia and serological evidence of anti-erythrocyte antibodies, detectable by the direct antiglobulin test DAT.

S—S [ PubMed ]. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Management of cold haemolytic syndrome. Autoimmune hemolytic anemia is characterized by the production of autoantibodies against erythrocyte membrane antigens. Management of hematological disorders and cancer.

  ALU 74181 PDF

A hepatic cirrhosis and hemolytic anemia is reported due to wd, in an female adolescent of age, with family antecedent of a sister with wd. Anemia hemolitica autoinmune malalties minoritaries. Clin Lymphoma Myeloma Leuk.

No adverse events were reported.

Treatment of autoimmune hemolytic anemias

Glucosephosphate dehydrogenase activity in male premature and term neonates. Autoimmune hemolytic anemia is rare in children and adolescents. McGraw-Hill, ; Cap Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia.

Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. The role and efficacy of antibiotic prophylaxis in this setting remains unclear, and not all investigators recommend this approach. Valent P, Lechner K. Rituximab in the treatment of refractory autoimmune cytopenias in adults. Autoimmune hemolytic anemia in children.

The mechanism of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Pediatr Dermatol, 28pp.

It can be idiopathic or secondary, and classified as warm, cold cold hemagglutinin disease CAD and paroxysmal cold hemoglobinuria or mixed, according to the thermal range of the autoantibody. In less urgent cases, an extended phenotyping is advisable and compatible red cell units may be selected for transfusion.

  APOSTILA DE FISICA TELECURSO 2000 PDF

The anti-CD20 monoclonal antibody rituximab has gained peviatria acceptance in the management of haematologic disorders with autoantibodies production.

The median follow-up period was 11 months 5 to 23 months. Arch Immunol Ther Exp.

Jornal de Pediatria

The most common indication was lupus nephritis LN Int J Hematol, 84pp. Efficacy and safety of treatment.

Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies. Verhoeven, and Dirk Roos. These atypical cases, which are identified with increasing frequency, may represent a critical autoinmhne problem and cause delays in therapy. Universidad de Costa Rica – Facultad de Medicina.